Recombinant Human RANK/TNFRSF11A/CD265 (C-6His)

Recombinant Human RANK/TNFRSF11A/CD265 (C-6His)
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
ABE-32-8632-10 10 µg - -

3 - 11 Werktage*

456,00 €
ABE-32-8632-50 50 µg - -

3 - 11 Werktage*

695,00 €
 
Source: Human Cells. MW :21.1kD. Recombinant Human Receptor Activator of NF-kappa-B is produced... mehr
Produktinformationen "Recombinant Human RANK/TNFRSF11A/CD265 (C-6His)"
Source: Human Cells. MW :21.1kD. Recombinant Human Receptor Activator of NF-kappa-B is produced by our Mammalian expression system and the target gene encoding Ile30-Pro212 is expressed with a 6His tag at the C-terminus. Receptor Activator of Nuclear Factor kappa B (RANK), also known as CD265, TRANCE Receptor or TNFRSF11A, is member of the tumor necrosis factor receptor (TNFR) molecular superfamily. RANK is the receptor for RANK-Ligand (RANKL) and part of the RANK/RANKL/OPG signaling pathway that regulates osteoclast differentiation and activation. It plays a vital role in bone remodeling and repair, immune cell function, lymph node development, thermal regulation, and mammary gland development. RANK is constitutively expressed in skeletal muscle, thymus, liver, colon, small intestine, adrenal gland, osteoclast, mammary gland epithelial cells, prostate, vascular cell, and pancreas. Protein function: Receptor for TNFSF11/RANKL/TRANCE/OPGL, essential for RANKL-mediated osteoclastogenesis. Involved in the regulation of interactions between T-cells and dendritic cells. [The UniProt Consortium]
Hersteller: Abeomics
Hersteller-Nr: 32-8632

Eigenschaften

Konjugat: No

Handhabung & Sicherheit

Lagerung: +20°C
Versand: +20°C (International: +20°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Recombinant Human RANK/TNFRSF11A/CD265 (C-6His)"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen